Future research on ACE in toxicology will likely focus on identifying novel ACE inhibitors with improved safety profiles, understanding genetic variations in ACE activity, and exploring its role in non-cardiovascular diseases. Advances in genomic and proteomic technologies will aid in uncovering new insights into ACE function and its interactions with various toxins. These efforts will enhance our ability to predict toxicological responses and develop innovative treatment strategies.
In conclusion, ACE is a vital enzyme with far-reaching implications in toxicology and pharmacology. By studying its interactions with various substances and environmental factors, toxicologists can better understand the complex mechanisms underlying cardiovascular health and disease, ultimately improving patient care and public health outcomes.
